Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions

N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions

US Patent 9329189 · Granted May 3, 2016

Estimated economic value: $58,116,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PHF-tau antibodies and uses thereof2025
Methods of binding amyloid beta protein having pyroglutamate at the third amino 2023
Methods of binding amyloid beta protein having pyroglutamate at the third amino 2023
Anti-PHF-tau antibodies and uses thereof2022
Antibodies to pyroglutamate amyloid-β and uses thereof2022
Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE 2020
Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE 2020
Anti-PHF-tau antibodies and uses thereof2020
Anti-PHF-tau antibodies and uses thereof2020
Antibodies to pyroglutamate amyloid-β and uses thereof2019
Antibodies to pyroglutamate amyloid-β and uses thereof2019
Anti-PHG-tau antibodies and their uses2019